<?xml version="1.0" encoding="UTF-8"?>
<p>On a global level, civil society bodies such as the World Hepatitis Alliance are instrumental in generating pressure on governments and international organisations, providing an evidence‐based approach to the response.
 <xref rid="liv14222-bib-0082" ref-type="ref">82</xref> Locally, robust evidence and civil society advocacy helped to achieve political commitment and facilitated the development of national plans. Collaboration and cooperation between civil society, the pharmaceutical industry and government smoothed the introduction of prevention and control programmes. Such unified, evidence‐informed strategies at the political and technical levels are crucial to attract and sustain commitment and financing. Learnings from these country examples and other local projects demonstrating the feasibility of elimination (eg micro‐elimination projects
 <xref rid="liv14222-bib-0036" ref-type="ref">36</xref>, 
 <xref rid="liv14222-bib-0099" ref-type="ref">99</xref>) can help persuade policymakers in other countries to support viral hepatitis prevention and control plans. In‐country and global advocacy must be maintained to keep viral hepatitis high on the political agenda.
 <xref rid="liv14222-bib-0082" ref-type="ref">82</xref>
</p>
